Taletrectinib promotes pyroptosis in colorectal carcinoma via SRC/AKT/mTOR axis inhibition

Abstract Drug resistance develops frequently after colorectal carcinoma (CRC) surgery, indicating the urgent need for new therapeutic strategies. Taletrectinib (DS-6051b/AB-106), a synthetic ROS1/NTRK inhibitor which has shown meaningful antitumor activity, is currently undergoing clinical trials ai...

Πλήρης περιγραφή

Λεπτομέρειες βιβλιογραφικής εγγραφής

Κύριοι συγγραφείς:	Ting Zhang, Ye Zou, Sun-Han Zhang, Yuan-Yi Wang, Shuang He, Wei Yuan, Min Yang, Teng Liu, Shi-Hua Deng, Dong-Ming Wu, Ying Xu
Μορφή:	Artigo
Γλώσσα:	Inglês
Έκδοση:	Nature Portfolio 2025-05-01
Σειρά:	Scientific Reports
Θέματα:	Colorectal carcinoma Taletrectinib Pyroptosis GSDME SRC
Διαθέσιμο Online:	https://doi.org/10.1038/s41598-025-02901-3
Ετικέτες:	Προσθήκη ετικέτας Δεν υπάρχουν, Καταχωρήστε ετικέτα πρώτοι!